- Home
- ANTX vs BNKK Comparison
ANTX vs BNKK Comparison
Compare ANTX & BNKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- BNKK
- Stock Information
- Founded
- ANTX 2017
- BNKK 2018
- Country
- ANTX United States
- BNKK United States
- Employees
- ANTX N/A
- BNKK N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- BNKK Package Goods/Cosmetics
- Sector
- ANTX Health Care
- BNKK Consumer Discretionary
- Exchange
- ANTX Nasdaq
- BNKK Nasdaq
- Market Cap
- ANTX 34.4M
- BNKK 38.6M
- IPO Year
- ANTX 2022
- BNKK 2020
- Fundamental
- Price
- ANTX $1.10
- BNKK $0.15
- Analyst Decision
- ANTX Buy
- BNKK
- Analyst Count
- ANTX 2
- BNKK 0
- Target Price
- ANTX $2.00
- BNKK N/A
- AVG Volume (30 Days)
- ANTX 96.8K
- BNKK 4.4M
- Earning Date
- ANTX 11-12-2025
- BNKK 11-14-2025
- Dividend Yield
- ANTX N/A
- BNKK N/A
- EPS Growth
- ANTX N/A
- BNKK N/A
- EPS
- ANTX N/A
- BNKK N/A
- Revenue
- ANTX N/A
- BNKK N/A
- Revenue This Year
- ANTX N/A
- BNKK N/A
- Revenue Next Year
- ANTX N/A
- BNKK N/A
- P/E Ratio
- ANTX N/A
- BNKK N/A
- Revenue Growth
- ANTX N/A
- BNKK 246.36
- 52 Week Low
- ANTX $1.00
- BNKK $0.13
- 52 Week High
- ANTX $1.68
- BNKK $1.34
- Technical
- Relative Strength Index (RSI)
- ANTX 36.23
- BNKK N/A
- Support Level
- ANTX $1.13
- BNKK N/A
- Resistance Level
- ANTX $1.17
- BNKK N/A
- Average True Range (ATR)
- ANTX 0.06
- BNKK 0.00
- MACD
- ANTX -0.01
- BNKK 0.00
- Stochastic Oscillator
- ANTX 0.00
- BNKK 0.00
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.